4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Graft versus host disease and microchimerism in a JAK3 deficient patient

      case-report

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The lymphohematopoietic cells originating from feto-maternal trafficking during pregnancy may cause microchimerism and lead to materno-fetal graft versus host disease (GVHD) in severe combined immunodeficiency (SCID) patients. However, definitive diagnosis between GVHD and Omenn’s syndrome is often difficult based on clinical and immunological phenotypes particularly in the patients with hypomorphic mutations.

          Case presentation

          A 3-year-old girl with a history of erythroderma and immunodeficiency was studied. The whole exome sequencing method was used to find the disease-causing variants, and T-A cloning and Quantitative Florescence Polymerase Chain Reaction (QF-PCR) methods were utilized to detect the presence of mosaicism or microchimerism. We identified a homozygous missense Janus Kinase 3 mutation ( JAK3, c.2324G>A, p.R775H) as a new disease-causing variant in the patient, and the presence of microchimerism with maternal origin was proven as an underlying cause of her clinical presentation.

          Conclusion

          The findings highlighted the importance of appropriate diagnostic approach in GVHD cases with hypomorphic JAK3 mutations. When analyzing the results of the next generation sequencing, the possibility of microchimerism should be considered based on the context of the disease.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Practice parameter for the diagnosis and management of primary immunodeficiency.

          The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

            This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the management of hematopoietic cell transplantation patients. Optimal sampling and tissue preparation are discussed. Minimal criteria for the diagnosis of graft-versus-host disease (GVHD) are proposed, together with specific requirements for the diagnosis of chronic GVHD. Four final diagnostic categories (no GVHD, possible GVHD, consistent with GVHD, and definite GVHD) reflect the integration of histopathology with clinical, laboratory, and radiographic information. Finally, the Working Group developed a set of worksheets to facilitate communication of clinical information to the interpreting pathologist and to aid in clinicopathologic correlation studies. Forms are available at . The recommendations of the Working Group represent a consensus opinion supplemented by evaluation of available peer-reviewed literature. Consensus recommendations and suggested data-capture forms should be validated in prospective clinicopathologic studies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Standards for Cell Line Authentication and Beyond

              Different genomic technologies have been applied to cell line authentication, but only one method (short tandem repeat [STR] profiling) has been the subject of a comprehensive and definitive standard (ASN-0002). Here we discuss the power of this document and why standards such as this are so critical for establishing the consensus technical criteria and practices that can enable progress in the fields of research that use cell lines. We also examine other methods that could be used for authentication and discuss how a combination of methods could be used in a holistic fashion to assess various critical aspects of the quality of cell lines.
                Bookmark

                Author and article information

                Contributors
                Z_shahbazi@pasteur.ac.ir
                nparvaneh@tums.ac.ir
                sh.shahbazi@modares.ac.ir
                rahimi.h1981@gmail.com
                hamid143@yahoo.com
                davidshahbazi1373@gmail.com
                sama.delavari@gmail.com
                abolhassanih@yahoo.com
                +982166428998 , aghamohammadi@tums.ac.ir
                +982166480780 , dr.reza.mahdian@gmail.com
                Journal
                Allergy Asthma Clin Immunol
                Allergy Asthma Clin Immunol
                Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
                BioMed Central (London )
                1710-1484
                1710-1492
                22 August 2019
                22 August 2019
                2019
                : 15
                : 47
                Affiliations
                [1 ]ISNI 0000 0000 9562 2611, GRID grid.420169.8, Molecular Medicine Department, , Pasteur Institute of Iran, ; Pasteur St., 12 Farvardin Ave., Tehran, 1316943551 Iran
                [2 ]GRID grid.414206.5, Research Center for Immunodeficiencies, Pediatrics Center of Excellence, , Children’s Medical Center, ; Tehran, Iran
                [3 ]ISNI 0000 0001 1781 3962, GRID grid.412266.5, Department of Medical Genetics, Faculty of Medical Sciences, , Tarbiat Modares University, ; Tehran, Iran
                [4 ]Shahid Hoseini School, Department of Education, Semirom, Isfahan Iran
                [5 ]ISNI 0000 0000 9241 5705, GRID grid.24381.3c, Division of Clinical Immunology, Department of Laboratory Medicine, , Karolinska Institute at Karolinska University Hospital Huddinge, ; Stockholm, Sweden
                [6 ]ISNI 0000 0001 0166 0922, GRID grid.411705.6, Department of Pediatrics, Children Medical Center Hospital, , Tehran University of Medical Science, ; Tehran, Iran
                Article
                361
                10.1186/s13223-019-0361-2
                6704686
                70dbb3d3-2cec-4c34-a19b-7551eeb4814a
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 26 January 2019
                : 12 August 2019
                Categories
                Case Report
                Custom metadata
                © The Author(s) 2019

                Immunology
                severe combined immunodeficiency,graft versus host disease,microchimerism,jak3 deficiency,short tandem repeat

                Comments

                Comment on this article